BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 29081996)

  • 1. Chronic kidney disease in low-income to middle-income countries: the case for increased screening.
    George C; Mogueo A; Okpechi I; Echouffo-Tcheugui JB; Kengne AP
    BMJ Glob Health; 2017; 2(2):e000256. PubMed ID: 29081996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The need for screening, early diagnosis, and prediction of chronic kidney disease in people with diabetes in low- and middle-income countries-a review of the current literature.
    George C; Echouffo-Tcheugui JB; Jaar BG; Okpechi IG; Kengne AP
    BMC Med; 2022 Aug; 20(1):247. PubMed ID: 35915501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for hyperglycemia in the developing world: rationale, challenges and opportunities.
    Echouffo-Tcheugui JB; Mayige M; Ogbera AO; Sobngwi E; Kengne AP
    Diabetes Res Clin Pract; 2012 Nov; 98(2):199-208. PubMed ID: 22975016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Detection of CKD: Implications for Low-Income, Middle-Income, and High-Income Countries.
    Tonelli M; Dickinson JA
    J Am Soc Nephrol; 2020 Sep; 31(9):1931-1940. PubMed ID: 32839279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for Kidney Disease in Low- and Middle-Income Countries.
    Kalyesubula R; Conroy AL; Calice-Silva V; Kumar V; Onu U; Batte A; Kaze FF; Fabian J; Ulasi I
    Semin Nephrol; 2022 Sep; 42(5):151315. PubMed ID: 37001337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the impact of screening, early identification and intervention programmes for chronic kidney disease: protocol for a scoping review.
    Okpechi IG; Caskey FJ; Gaipov A; Tannor EK; Hamonic LN; Ashuntantang G; Donner JA; Figueiredo A; Inagi R; Madero M; Malik C; Moorthy M; Pecoits-Filho R; Tesar V; Levin A; Jha V
    BMJ Open; 2021 Dec; 11(12):e053857. PubMed ID: 34916325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
    Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
    Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on Existing Care Models for Chronic Kidney Disease in Low- and Middle-Income Countries: A Systematic Review.
    Nkunu V; Wiebe N; Bello A; Campbell S; Tannor E; Varghese C; Stanifer J; Tonelli M
    Can J Kidney Health Dis; 2022; 9():20543581221077505. PubMed ID: 35251672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of chronic kidney disease and its risk-attributable burden in 137 low-and middle-income countries, 1990-2019: results from the global burden of disease study 2019.
    Ke C; Liang J; Liu M; Liu S; Wang C
    BMC Nephrol; 2022 Jan; 23(1):17. PubMed ID: 34986789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Yield of Population-Based Screening for Chronic Kidney Disease in Low-Income, Middle-Income, and High-Income Countries.
    Tonelli M; Tiv S; Anand S; Mohan D; Garcia Garcia G; Gutiérrez Padilla JA; Klarenbach S; Navarro Blackaller G; Seck S; Wang J; Zhang L; Muntner P
    JAMA Netw Open; 2021 Oct; 4(10):e2127396. PubMed ID: 34605917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data Challenges in Addressing Chronic Kidney Disease in Low- and Lower-Middle-Income Countries.
    Talbot B; Athavale A; Jha V; Gallagher M
    Kidney Int Rep; 2021 Jun; 6(6):1503-1512. PubMed ID: 34169191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do attributes of persons with chronic kidney disease differ in low-income and middle-income countries compared with high-income countries? Evidence from population-based data in six countries.
    Anand S; Zheng Y; Montez-Rath ME; Wei WJ; Perico N; Carminati S; Narayan KV; Tandon N; Mohan V; Jha V; Zhang L; Remuzzi G; Prabahkaran D; Chertow GM
    BMJ Glob Health; 2017; 2(4):e000453. PubMed ID: 29071132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling Chronic Kidney Disease in Type 2 Diabetes Mellitus: A Systematic Literature Review of Models, Data Sources, and Derivation Cohorts.
    Pöhlmann J; Bergenheim K; Garcia Sanchez JJ; Rao N; Briggs A; Pollock RF
    Diabetes Ther; 2022 Apr; 13(4):651-677. PubMed ID: 35290625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Kidney Disease.
    Webster AC; Nagler EV; Morton RL; Masson P
    Lancet; 2017 Mar; 389(10075):1238-1252. PubMed ID: 27887750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Low Socioeconomic Status on Progression of Chronic Kidney Disease in Low- and Lower Middle-Income Countries.
    Tannor EK; Chika OU; Okpechi IG
    Semin Nephrol; 2022 Sep; 42(5):151338. PubMed ID: 36966563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing CKD in Developed Countries.
    Luyckx VA; Cherney DZI; Bello AK
    Kidney Int Rep; 2020 Mar; 5(3):263-277. PubMed ID: 32154448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention programs for chronic kidney disease in low-income countries.
    Perico N; Remuzzi G
    Intern Emerg Med; 2016 Apr; 11(3):385-9. PubMed ID: 26983956
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.